Rosanne Rotondo

Rosanne Rotondo is a senior executive at Novartis, currently serving as the Head of Global Health Access for Novartis Global Health.3 She has over 30 years of progressive experience in the global pharmaceutical industry, demonstrating significant leadership in her field.2

Career at Novartis

Rotondo has held various positions within Novartis, showcasing her expertise in global health initiatives:

1. Head of Global Health Access (current role)3
2. Head of Global Health Flagship Programs (previous role)1

In her current position, Rotondo focuses on leading sustainable programs to improve access to medicines and enhance healthcare systems globally. Her work involves addressing major, unresolved global health challenges by leveraging Novartis' expertise and organizational capabilities.1

Global Health Initiatives

Rotondo has been instrumental in advancing Novartis' four flagship programs, which target:

1. Leprosy
2. Malaria
3. Sickle Cell Disease
4. Chagas Disease

She has been particularly involved in the Leprosy Post-Exposure Prophylaxis (LPEP) program, which aims to reduce the risk of leprosy among those potentially exposed to the disease.1

Expertise and Recognition

Rotondo is known for her extensive experience in:

• Healthcare equity
• Global health access
• Sustainable healthcare programs

Her expertise has led to her appointment as a member of The Lancet Global Health Commission on People-Centered Care for Universal Health Coverage4, highlighting her influence in the field of global health.

Professional Network

Rosanne Rotondo maintains an active presence on professional networks:

• LinkedIn: Her profile can be found under the username rosanne-rotondo-7058a41a2
• She has over 500 connections on LinkedIn, indicating a strong professional network in the pharmaceutical and global health sectors2

Through her role at Novartis and her involvement in various global health initiatives, Rosanne Rotondo continues to make significant contributions to improving health outcomes worldwide.